Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Randomized Controlled Trial Of Dalteparin For Primary Thromboprophylaxis For Venous Thromboembolism (VTE) In Patients With Advanced Pancreatic Cancer (APC): Risk Factors Predictive Of VTE

Saroj Vadhan-Raj, MD, Xiao Zhou, MD, PhD, Gauri R. Varadhachary, MD, MBBS, Javle Milind, MD, David Fogelman, MD, Rachna Shroff, MD, Carlos E. Bueso-Ramos, MD, PhD, Martin Nguyen, BS, Xuemei Wang, MS, Robert A. Wolff, MD, James L. Abbruzzese, MD, Michael J. Overman, MD

Blood (2013) 122 (21): 580.

https://doi.org/10.1182/blood.V122.21.580.580

Published: 2013

Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

Owen A O'Connor, J. Gerecitano, H. Van Deventer, B. Afanasyev, J. Hainsworth, M. Chen, K. Saikali, J. Seroogy, R. Escandon, A. Wolff, MG. Conlan

Blood (2009) 114 (22): 1673.

https://doi.org/10.1182/blood.V114.22.1673.1673

Published: 2009

Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff

Blood (2008) 112 (11): 1563.

https://doi.org/10.1182/blood.V112.11.1563.1563

Published: 2008

Journal Articles

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Gary H. Lyman, MD, MPH, FRCP, Jeffrey Crawford, MD, Nicole M. Kuderer, MD, Debra A. Wolff, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, David C. Dale, MD

Blood (2007) 110 (11): 372.

https://doi.org/10.1182/blood.V110.11.372.372

Published: 2007

Journal Articles

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

Gary H. Lyman, MD, MPH, FRCP, David C. Dale, MD, Nicole M. Kuderer, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Jeffrey Crawford, MD, for the ANC Study Group

Blood (2006) 108 (11): 460.

https://doi.org/10.1182/blood.V108.11.460.460

Published: 2006

Journal Articles

First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.

Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Eva Culakova, PhD, Marek S. Poniewierski, MD, MS, Caleb Selby, David C. Dale, MD, Gary H. Lyman, MD, MPH, for the ANC Study Group

Blood (2004) 104 (11): 2210.

https://doi.org/10.1182/blood.V104.11.2210.2210

Published: 2004

Journal Articles

Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study.

David C. Dale, MD, Jeffrey Crawford, MD, Debra A. Wolff, MS, PCNP, Marek S. Poniewierski, MD, MS, Eva Culakova, PHD, Gary H. Lyman, MD, MPH, for the ANC Study Group

Blood (2004) 104 (11): 4599.

https://doi.org/10.1182/blood.V104.11.4599.4599

Published: 2004

Journal Articles

Assessment of Hematologic and Non-Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Registry.

Naeem Tahir, MD, Jerome H. Goldschmidt, MD, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Debra A. Wolff, MS, PCNP, David C. Dale, MD, Jeffrey Crawford, MD, Gary H. Lyman, MD, MPH

Blood (2004) 104 (11): 3131.

https://doi.org/10.1182/blood.V104.11.3131.3131

Published: 2004

Journal Articles

"Impotent" Platelets in Albinos With Prolonged Bleeding Times

Harold M. Maurer, M.D., James A. Wolff, M.D., Sue Buckingham, M.D., Arthur R. Spielvogel, M.D.

Blood (1972) 39 (4): 490–499.

https://doi.org/10.1182/blood.V39.4.490.490

Published: 1972

Journal Articles

The Comparison of 6-Mercaptopurine with the Combination of 6-Mercaptopurine and Azaserine in the Treatment of Acute Leukemia in Children: Results of a Cooperative Study

R. M. HEYN, C. A. BRUBAKER, J. H. BURCHENAL, H. G. CRAMBLETT, J. A. WOLFF

Blood (1960) 15 (3): 350–359.

https://doi.org/10.1182/blood.V15.3.350.350

Published: 1960

Journal Articles

Hemoglobin H-Thalassemia Disease

JAMES A. WOLFF, RICHARD H. MICHAELS, FREDERICK H. VON HOFE

Blood (1958) 13 (5): 492–501.

https://doi.org/10.1182/blood.V13.5.492.492

Published: 1958

Journal Articles

Familial Erythroid Multinuclearity

JAMES A. WOLFF, M.D., FREDERICK H. VON HOFE, M.D.

Blood (1951) 6 (12): 1274–1283.

https://doi.org/10.1182/blood.V6.12.1274.1274

Published: 1951

NARROW

Randomized Controlled Trial Of Dalteparin For Primary Thromboprophylaxis For Venous Thromboembolism (VTE) In Patients With Advanced Pancreatic Cancer (APC): Risk Factors Predictive Of VTE

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

A Conditional Risk Model for Chemotherapy-Induced Anemia (CIA) in Cancer Patients.

Prospective Validation of a Predictive Model for Early Anemia in Patients Receiving Cancer Chemotherapy.

First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study.

Predicting the Risk of Neutropenic Complications and Reduced Dose Intensity in Patients with Malignant Lymphoma: Results from a Prospective Study.

Assessment of Hematologic and Non-Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Registry.

"Impotent" Platelets in Albinos With Prolonged Bleeding Times

The Comparison of 6-Mercaptopurine with the Combination of 6-Mercaptopurine and Azaserine in the Treatment of Acute Leukemia in Children: Results of a Cooperative Study

Hemoglobin H-Thalassemia Disease

Familial Erythroid Multinuclearity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only